SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
50728They haven't talked about NASH recently to my knowledge. They did start a Biomaven-2/12/2019
50727FGEN FG-3019 in NASH I think this has been addressed before but can't rememjb118-2/12/2019
50726The role of the gut virome appears to be even less well understood: ncbi.nlm.ninigel bates-2/11/2019
50725That is interesting - I've learned more about this since owning Anavex stockXenaLives-2/6/2019
50724alzforum.org i suggest that you read the comments section, especially the one bsoftware salesperson32/6/2019
50723It's not just epigenetic - each person's immune system has a say in the Biomaven-2/5/2019
50722healthsystemtracker.org What are the recent and forecasted trends in prescriptisoftware salesperson-2/5/2019
50721Cortexyme is probably looking to IPO...XenaLives-2/5/2019
50720IMO - more likely to be epigenetic factors which influence gut microbiome and BBXenaLives-2/5/2019
50719Bernie coming after CPRX... thehill.comnigel bates-2/4/2019
50718A human gut bacterial genome and culture collection for improved metagenomic ananigel bates-2/4/2019
50717<that MDGL/VKTX results crush those of BMY's FGF21 by an order of magnituMiljenko Zuanic-1/31/2019
50716NASH drug is for pro-/pre-diabetic, obese, triglyceride,....or some other co-morMiljenko Zuanic-1/31/2019
50715Yes Miljenko, I agree. I wonder if the placebo group in VKTX Ph2 were on an exeatticus4paws-1/31/2019
50714here's the info, not super easy to find directly, along with some on prior toldirtybastard11/31/2019
50713I think you need an oral drug for this sort of condition. Compliance otherwise vBiomaven11/31/2019
50712Placebo group in VKTX/MDGL trials have higher relative and absolute liver fat reMiljenko Zuanic-1/31/2019
50711Thanks Miljenko. 10 mg pegbelfermin daily (-6·8% vs -1·3%; p=0·0atticus4paws-1/31/2019
50710Regards the PEG-FGF21 and this P2b ( clinicaltrials.gov ), If someone know regimMiljenko Zuanic-1/31/2019
50709David Grainger is knowledgeable, maybe very knowledgeable, so it is worthy to doMiljenko Zuanic-1/31/2019
50708In the interest filling the void that's developed at SI over the last few daatticus4paws-1/31/2019
50707Gut bacteria linked to AD, Parkinson's, epilepsy etc...+ lack of L. reuteri biocqr11/29/2019
50706NY Times 2014 on fish oil... What’s in Your Fish Oil Supplements? The new resebiocqr11/26/2019
50705For folks interested in HIF-1.alpha (FGEN) and metabolism (AMPK, mTOR, ATP), heratticus4paws-1/26/2019
50704It's certainly an interesting study - I'll have to read more thoroughly.Biomaven-1/24/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News